Awardee OrganizationSOUTHERN ILLINOIS UNIVERSITY CARBONDALE
Description
Abstract Text
The project is designed to explore the chemistry of boron-containing purine
ribonucleoside analogs with the long-term objective of demonstrating that
the judicious positioning of the boron atom in the bicyclic ring
heterocyclic system results in the formation of reasonably stable and quite
interesting derivatives. The results of this project should serve to
illustrate the concept of substituting a boron-oxygen single bond for a
naturally-occurring carbon-nitrogen double bond, or of a boron-nitrogen
single bond for a naturally-occurring carbon-carbon double bond to provide
stable analogs possessing unique and useful properties. In specific, the
target compounds of this proposal are expected to be inhibitors of the
enzyme adenosine deaminase, by virtue of the placement of the boron atom at
that carbon-atom position which is deaminated in vivo. The formation of a
tetrahedral borate moiety at the enzyme's active site is proposed, and
should result in the process known as transition-state analog inhibition.
Inhibitors of adenosine deaminase are of importance in potentiating the
effect of the antitumor agent arabinosyl-adenosine. In addition to the
specific aim of developing ADase inhibitors, this work will provide a new
class of stable boron-containing purine aglycon and nucleoside derivatives,
for study in a variety of health-related areas. The examination of
potential antitumor, antibacterial, and especially antiviral activities of
these nucleosides will be of great interest. The examination of
hydrogen-bonding schemes and the potential for incorporation in to the
cellular DNA br RNA pools are other aspects expected to arise from this
work. The present proposal seeks to prepare some representative members of
this new class of nucleoside analogs in sufficient quantities for a
detailed examination of their physicochemical properties and for a
determination of enzymatic activity as well. The design of these analogs
is based upon their similarity to known boron heterocycles of proven
hydrolytic stability and upon their energy-stabilizing locus of the boron
atom at the 6-position (purine ring numbering) of the bicyclic ring. The
methods to be used in achieving their synthesis are based upon a sequential
halogen-metal exchange methodology coupled with documented dehydrative
ring-closure methodologies of arylboronic acid compounds.
No Sub Projects information available for 1R29GM044819-01A3
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R29GM044819-01A3
Patents
No Patents information available for 1R29GM044819-01A3
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R29GM044819-01A3
Clinical Studies
No Clinical Studies information available for 1R29GM044819-01A3
News and More
Related News Releases
No news release information available for 1R29GM044819-01A3
History
No Historical information available for 1R29GM044819-01A3
Similar Projects
No Similar Projects information available for 1R29GM044819-01A3